piribedil has been researched along with levodopa in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (66.20) | 18.7374 |
1990's | 2 (2.82) | 18.2507 |
2000's | 13 (18.31) | 29.6817 |
2010's | 7 (9.86) | 24.3611 |
2020's | 2 (2.82) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Quik, M; Sourkes, TL | 1 |
Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A | 1 |
Bastard, J; Chanelet, J; Emile, J; Six, P; Truelle, JL | 2 |
Hungerbühler, JP; Regli, F | 1 |
Chase, T; Shoulson, I | 1 |
Battista, AF; Goldstein, M; Miyamoto, T | 1 |
Cramer, H; Kiessling, M; Lindl, T | 1 |
Cramer, H; Kiessling, M | 1 |
Carolei, A; Margotta, V; Palladini, G | 1 |
Agid, Y; Barroche, G; Bonnet, AM; Javoy-Agid, F; Kato, G; Lhermitte, F; Pollak, P; Signoret, JL | 1 |
Gershon, S; Shopsin, B | 1 |
Barbeau, A; Bélanger, F; Butterworth, RF | 1 |
Chase, TN; Shoulson, I | 2 |
Barbeau, A | 1 |
Poirier, LJ | 1 |
Pohto, P | 1 |
Agnati, L; Fuxe, K; Hökfelt, T; Löfstöm, A | 1 |
Angrist, B; Gershon, S | 1 |
Gardner, EL; Glusman, N; Logan, N; Marotta, RF; Potegal, M | 1 |
Marttila, R; Rinne, UK; Sonninen, V | 2 |
Feigenson, JS; McDowell, FH; Sweet, RD | 1 |
Gräf, HJ; Horowski, R | 1 |
Bathien, N; Dumas, JL; Rondot, P | 1 |
Callaghan, N; Fitzpatrick, E; O'Mahony, JB | 1 |
Bastard, J; Chanelet, J; Emile, J; Truelle, JL | 1 |
Costall, B; Naylor, RJ | 1 |
Buckett, WR; Shaw, JS | 1 |
Jenner, P; Marsden, CD | 1 |
Agnoli, A; Carolei, A; Cerbo, R; Meco, G; Ruggieri, S; Zamponi, A | 1 |
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
Allain, H; Bentue-Ferrer, D; Decombe, R; Lemaitre, MH; Martinet, JP; Milon, D | 1 |
Dahl, CB; Götestam, KG | 1 |
Goldstein, M; Lloyd, KG; Willigens, MT | 1 |
Akpinar, S | 1 |
Agid, Y; Dubois, B | 1 |
Kapfhammer, HP; Rüther, E | 1 |
Caccia, MR; Mangoni, A | 1 |
McDowell, FH; Sweet, RD; Wasterlain, C | 1 |
Burton, K; Calne, DB | 1 |
Bathien, N; Koutlidis, RM; Rondot, P | 1 |
Andreeva, OG; Korovin, KF; Ostroumova, MN; Schelkunov, EL | 1 |
Kurako, IuL; Volianskiĭ, VE | 1 |
Cheal, M | 1 |
Ambrosoli, C; Armocida, G; Finavera, L; Majeron, MA; Quisi, Q | 1 |
Broekkamp, CL | 1 |
Fournet, N; Moreaud, O; Naegele, B; Pellat, J; Roulin, JL | 1 |
Bonnet, AM | 1 |
Bonhomme, C; Braceras, R; Chezaubernard, C; Del Signore, S; Hansard, MJ; Jackson, MJ; Jenner, P; Rose, S; Smith, LA; Tel, BC | 1 |
Gekht, AB | 2 |
Castro-Caldas, A; Del Signore, S; Rascol, O; Ziegler, M | 1 |
Carbajal, LO; Domingo, FM; Esteban, RP; Evidente, VG; Parazo, MA | 1 |
Fedorova, NV | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Bundhukul, A; Chankrachang, S; Laptikultham, S; Nidhinandana, S; Pisarnpong, A; Srisuwananukorn, S; Suwantamee, J | 1 |
Artem'ev, DV | 1 |
Amalric, M; Baunez, C; Chezaubernard, C; Maurin, B; Morain, P; Nieoullon, A; Puma, C; Turle-Lorenzo, N | 1 |
Caldas, AC; Del Signore, S; Dubois, B; Lees, A; Rascol, O; Senn, S | 1 |
Dunnett, SB; Lane, EL | 1 |
Budrewicz, S; Jaskólska, A; Jaskólski, A; Koszewicz, M; Marusiak, J | 1 |
Gerlach, M; Halley, P; Riederer, P; van den Buuse, M | 1 |
Ma, YZ; Shen, XM; Zhang, J | 1 |
Cao, ZH; Chen, HX; Ding, ZG; Song, JH; Zhang, GB; Zhou, PY | 1 |
Fedorova, NV; Gubanova, ЕN; Kulua, TK | 1 |
Pilipovich, AA; Vorob'eva, OV | 2 |
9 review(s) available for piribedil and levodopa
Article | Year |
---|---|
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine | 1979 |
Progress in understanding and treating Parkinson's disease.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Enzyme Inhibitors; Ergot Alkaloids; Humans; Levodopa; Parkinson Disease; Peptides; Phenethylamines; Piribedil | 1976 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
[Alpha-2 adrenergic receptors and Parkinson's disease].
Topics: Adrenergic alpha-2 Receptor Antagonists; Antiparkinson Agents; Humans; Levodopa; Neuroprotective Agents; Norepinephrine; Parkinson Disease; Piribedil; Receptors, Adrenergic, alpha-2 | 2002 |
[Use of dopamine analogs in Parkinson's disease treatment].
Topics: Dopamine; Dopamine Agents; Humans; Levodopa; Parkinson Disease; Piribedil; Treatment Outcome | 2002 |
[Treatment of Parkinson's disease: use of piribedil].
Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Piribedil | 2004 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
15 trial(s) available for piribedil and levodopa
Article | Year |
---|---|
Caffeine and the antiparkinsonian response to levodopa or piribedil.
Topics: Adult; Aged; Caffeine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil | 1975 |
[Long-term clinical and electrophysiological study of a new dopaminergic agonist in 54 patients with parkinsonism].
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Electrophysiology; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil | 1977 |
Clonidine and the anti-parkinsonian response to L-DOPA or piribedil.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Clonidine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Placebos | 1976 |
Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Muscle Tonus; Parkinson Disease; Piperazines; Piribedil; Reflex, Monosynaptic; Tremor | 1975 |
Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
Topics: Aged; Brain; Clinical Trials as Topic; Dopamine; Drug Evaluation; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Placebos; Serotonin | 1975 |
Piribedil (ET 495) in the treatment of Parkinson's disease combined with amantadine or levodopa.
Topics: Aged; Amantadine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Placebos | 1975 |
[Polygraphic recording of tremor and of hypertonic phenomena. Application to the action of various drugs].
Topics: Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Dopa Decarboxylase; Drug Combinations; Drug Evaluation; Electrodiagnosis; Electromyography; Humans; Levodopa; Medical Records; Muscle Tonus; Oscillometry; Parkinson Disease; Piribedil; Tremor | 1975 |
Restless legs syndrome treatment with dopaminergic drugs.
Topics: Adult; Aged; Benserazide; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Piribedil; Random Allocation; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders | 1987 |
Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
Topics: Adult; Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil; Treatment Outcome | 2003 |
Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience.
Topics: Adult; Aged; Asian People; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil; Prospective Studies; Statistics, Nonparametric | 2003 |
[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
Topics: Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Piribedil; Placebos; Time Factors; Treatment Outcome | 2003 |
Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study.
Topics: Adult; Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil | 2004 |
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
Topics: Adult; Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Piribedil; Severity of Illness Index; Single-Blind Method; Time Factors | 2006 |
Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson's disease: study protocol of a multicenter, open-label, randomized active-controlled trial.
Topics: Benserazide; Data Interpretation, Statistical; Drug Combinations; Drugs, Chinese Herbal; Humans; Levodopa; Medicine, Chinese Traditional; Parkinson Disease; Phytotherapy; Piribedil; Quality of Life | 2013 |
Rhythmic auditory stimulation with visual stimuli on motor and balance function of patients with Parkinson's disease.
Topics: Acoustic Stimulation; Aged; Benserazide; Benzothiazoles; Catechols; Dose-Response Relationship, Drug; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Periodicity; Piribedil; Postural Balance; Pramipexole; Walking | 2015 |
47 other study(ies) available for piribedil and levodopa
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase | 1977 |
[Therapy of Parkinson's disease. Practical criteria of treatment].
Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol | 1976 |
[Piribedil, dopaminergic agonist. Prolonged clinical and electrophysiological study in 60 parkinsonian patients (author's transl)].
Topics: Administration, Oral; Adrenergic Agonists; Aged; Drug Therapy, Combination; Electromyography; Female; Humans; Injections, Intravenous; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Receptors, Dopamine | 1977 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
Cyclic adenosinemonophosphate in cerebrospinal fluid. Effects of theophylline, L-dopa and a dopamine receptor stimulant in rats.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Cyclic AMP; Dose-Response Relationship, Drug; Levodopa; Male; Papaverine; Phentolamine; Piperazines; Piribedil; Propranolol; Rats; Receptors, Drug; Stimulation, Chemical; Time Factors | 1975 |
[Effects of levodopa and piribedil on cyclic AMP levels in cerebrospinal fluid in rats (author's transl)].
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Cyclic AMP; Dopamine; Levodopa; Male; Phentolamine; Piperazines; Piribedil; Propranolol; Rats | 1976 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bromocriptine; Depression; Female; Hostility; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Piperazines; Piribedil; Receptors, Dopamine; Syndrome | 1978 |
Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs.
Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Dopamine; Hydroxydopamines; Hypothalamus; Hypothalamus, Anterior; Levodopa; Male; Models, Neurological; Motor Activity; Norepinephrine; Piribedil; Rats; Receptors, Dopamine; Serotonin; Tyrosine | 1978 |
Dopaminergic agonists in animal models of parkinsonism.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Cats; Disease Models, Animal; Haplorhini; Levodopa; Parkinson Disease, Secondary; Piribedil; Rats; Reserpine; Tyrosine | 1975 |
A neuropharmacological approach to experimental bruxism.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Bruxism; Drug Synergism; Levodopa; Male; Mastication; Methylphenidate; Piribedil; Rats; Scopolamine; Theophylline; Time Factors | 1977 |
Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats.
Topics: Animals; Apomorphine; Carbidopa; Dopamine; Ergot Alkaloids; Female; Gonadotropins, Equine; Hypothalamo-Hypophyseal System; Levodopa; Lysergic Acid Diethylamide; Median Eminence; Norepinephrine; Ovulation; Piribedil; Pregnancy; Rats; Receptors, Adrenergic; Receptors, Dopamine | 1977 |
Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects.
Topics: Amphetamine; Dextroamphetamine; Dopamine; Humans; Levodopa; Male; Paranoid Disorders; Piribedil; Psychoses, Substance-Induced; Schizophrenia | 1977 |
Dopamine agonists induce recovery from surgically-induced septal rage.
Topics: Amphetamines; Anger; Animals; Apomorphine; Behavior, Animal; Levodopa; Male; Piribedil; Rage; Rats; Receptors, Dopamine; Septal Nuclei; Time Factors | 1977 |
Brain dopamine turnover and the relief of parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parkinson Disease; Piperazines; Piribedil; Probenecid; Receptors, Dopamine | 1977 |
Piribedil: its synergistic effect in multidrug regimens for parkinsonism.
Topics: Aged; Amantadine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Movement Disorders; Parasympatholytics; Parkinson Disease; Piperazines; Piribedil | 1976 |
Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
Topics: Animals; Apomorphine; Benserazide; Clonidine; Dextroamphetamine; Dopamine; Female; Haloperidol; Hypophysectomy; Levodopa; Male; Methyltyrosines; Piribedil; Pituitary Gland; Prolactin; Rats; Reserpine; Sulpiride; Transplantation, Homologous | 1976 |
Dopaminergic mechanisms in patients with extrapyramidal disease.
Topics: Animals; Biogenic Amines; Brain; Caffeine; Clonidine; Dopamine; Drug Evaluation; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parasympatholytics; Parkinson Disease; Piperazines; Piribedil; Pituitary Gland, Anterior; Prolactin; Rats; Receptors, Drug; Stimulation, Chemical | 1975 |
Actions of dopaminergic agonists on motor function.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Antagonists; Humans; Hyperkinesis; Levodopa; Methylphenidate; Motor Activity; Movement Disorders; Phenethylamines; Piribedil; Rats; Stereotyped Behavior; Tyrosine | 1975 |
Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Benztropine; Cyclazocine; Dopamine; Dose-Response Relationship, Drug; Humans; Levallorphan; Levodopa; Male; Motor Activity; Naloxone; Piribedil; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1975 |
The influence of piribedil (ET495) on components of locomotor activity.
Topics: Amphetamine; Animals; Apomorphine; Brain; Clonidine; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Mice; Motor Activity; Norepinephrine; Piperazines; Piribedil; Reserpine; Time Factors | 1975 |
[Animal stereotypy and transmethylation of cerebral amines].
Topics: Amines; Amphetamine; Animals; Apomorphine; Brain; Levodopa; Movement Disorders; Piribedil; Rats; S-Adenosylmethionine | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease.
Topics: Aged; Aging; Blood Pressure; Bromocriptine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Piribedil; Receptors, Adrenergic, beta | 1991 |
An open field study of antidepressant drugs.
Topics: Albuterol; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Dibenzazepines; Dibenzocycloheptenes; Levodopa; Male; Motor Activity; Nomifensine; Piracetam; Piribedil; Rats; Rats, Inbred Strains; Viloxazine | 1989 |
Induction and reversal of dopamine dyskinesia in rat, cat, and monkey.
Topics: Animals; Apomorphine; Brain; Cats; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Haplorhini; Humans; Levodopa; Motor Activity; Muscimol; Nomifensine; Piribedil; Rats; Receptors, Dopamine; Receptors, GABA-A; Stereotyped Behavior | 1985 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
[Dopamine agonists in the therapy of parkinson syndrome].
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Bromocriptine; Corpus Striatum; Dopamine; Humans; Levodopa; Lisuride; Neural Pathways; Parkinson Disease; Piribedil; Receptors, Dopamine; Substantia Nigra | 1985 |
Clonidine in essential tremor: preliminary observations from an open trial.
Topics: Aged; Clonidine; Diazepam; Female; Handwriting; Humans; Levodopa; Male; Middle Aged; Piribedil; Tremor | 1985 |
Piribedil--an oral dopamine agonist for treatment of Parkinson's disease.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil | 1974 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
[Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
Topics: Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Electromyography; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine | 1981 |
The functional role of the noradrenergic neurons in the thermoregulatory circuits in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Biogenic Amines; Body Temperature Regulation; Brain; Bromocriptine; Female; Hydroxydopamines; Kinetics; Levodopa; Male; Mice; Mice, Inbred Strains; Neurons; Norepinephrine; Piribedil | 1981 |
L-Dopa and piribedil alter different components of attentional behavior dependent on dose.
Topics: Animals; Attention; Behavior, Animal; Carbidopa; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Gerbillinae; Levodopa; Male; Motor Activity; Piperazines; Piribedil; Time Factors | 1983 |
[Attempted direct etiological treatment of Huntington's chorea. Case reports].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disease; Levodopa; Middle Aged; Piperazines; Piribedil | 1980 |
Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
Topics: Animals; Apomorphine; Cats; Dextroamphetamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Nomifensine; Piribedil; Receptors, Dopamine; Stereotyped Behavior | 1982 |
The phonological loop in medicated patients with Parkinson's disease: presence of phonological similarity and word length effects.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory; Parkinson Disease; Phonetics; Piribedil; Severity of Illness Index; Verbal Behavior | 1997 |
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Arousal; Callithrix; Caudate Nucleus; Corpus Striatum; Culture Techniques; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dyskinesias; Female; In Situ Hybridization; Levodopa; Locomotion; Male; Piribedil; RNA, Messenger; Severity of Illness Index; Time Factors | 2002 |
[Modern aproaches to the treatment of early stages of Parkinson disease].
Topics: Adult; Aged; Amantadine; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Piribedil; Severity of Illness Index | 2005 |
The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Cognition; Corpus Striatum; Dopamine Agonists; Drug Therapy, Combination; Levodopa; Male; Mazindol; Motor Activity; Parkinson Disease; Piribedil; Rats; Rats, Wistar; Reaction Time | 2006 |
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Oxidopamine; Parkinsonian Disorders; Piribedil; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation; Time Factors | 2010 |
Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Electromyography; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Muscle Contraction; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Piribedil; Stress, Mechanical | 2012 |
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antiparkinson Agents; Benserazide; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Facial Asymmetry; Idazoxan; Levodopa; Locomotion; Oxidopamine; Parkinson Disease; Piribedil; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Statistics, Nonparametric; Upper Extremity | 2013 |
[The use of piribedil in early and late stages of Parkinson's disease].
Topics: Antiparkinson Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Piribedil | 2015 |
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil; Quality of Life; Sialorrhea; Upper Gastrointestinal Tract | 2022 |
[Motor and autonomic disorders influence on pain syndrome of patients with Parkinson's disease of the I-III H&Y stages].
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil; Quality of Life | 2023 |